Poster

Patient-derived hiPSCs as a resource for modelling Huntington’s disease

The multiplatform utility of human iPSC-derived neuronal models to provide complex biological in vitro systems for drug discovery

The multiplatform utility of human iPSC-derived neuronal models

Characterization of striatal neurons derived from >140 CAG iPSCs for Huntington’s Disease modeling

Characterization of striatal neurons derived from 140 CAG iPSCs for Huntington’s Disease modeling

Phenotypically characterized iPSC biological components to generate next generation NMJ models for enhancing breakthroughs in ALS treatment

Human iPSC-derived cardiomyocytes for high throughput in vitro cardiac pharmacology and cardiotoxicity studies

High-throughput automated patch-clamp analysis reveals altered excitability and variation of ion channel activity in ALS iPSC-derived motor neurons

Human iPSC-derived motor neurons for ALS modeling on the high-throughput Nanion SyncroPatch 384 platform

Characterization of patient iPSCs-derived striatal neurons with >140 CAG repeats in 100 day-culture

Validation of a cortical tri-culture axoModel for in vitro compound screening a blinded compound study

Validation of a cortical tri-culture axoModel for in vitro

Harnessing the potential of induced pluripotent stem cells to accelerate drug discovery for age-related macular degeneration